# Sex Hormone Binding Globulin, Testosterone and Glycemic Control in Patients With Type 2 Diabetes

> **NCT03519529** · — · COMPLETED · sponsor: **Nanjing First Hospital, Nanjing Medical University** · enrollment: 250 (actual)

## Conditions studied

- Type2 Diabetes

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03519529
- **Lead sponsor:** Nanjing First Hospital, Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-01
- **Primary completion:** 2018-04-15
- **Final completion:** 2018-04-20
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2018-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03519529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03519529, "Sex Hormone Binding Globulin, Testosterone and Glycemic Control in Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT03519529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*